MeSH term
Frequency | Condition_Probility | Hela Cells | 2 | 0.0 |
Humans | 54 | 0.0 |
Research Support, Non-U.S. Gov't | 35 | 0.0 |
Up-Regulation | 2 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Intercellular Adhesion Molecule-1/genetics | 3 | 10.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Intercellular Adhesion Molecule-1/*genetics | 5 | 21.0 |
Molecular Sequence Data | 8 | 0.0 |
Antioxidants/*pharmacology | 2 | 1.0 |
Cell Line | 6 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Infant | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Binding Sites | 4 | 0.0 |
Intercellular Adhesion Molecule-1/metabolism | 3 | 1.0 |
Jurkat Cells | 2 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Transfection | 4 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Viral Matrix Proteins/genetics/*metabolism | 2 | 10.0 |
Adolescent | 5 | 0.0 |
Adult | 16 | 0.0 |
Female | 19 | 0.0 |
Male | 19 | 0.0 |
Middle Aged | 15 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Animals | 13 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Down-Regulation | 2 | 0.0 |
Rats | 2 | 0.0 |
Bone Marrow Cells/cytology/metabolism | 2 | 10.0 |
Cell Adhesion | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Mice | 7 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Cell Division | 4 | 0.0 |
Immunohistochemistry | 10 | 0.0 |
Antibodies, Monoclonal | 6 | 0.0 |
Cell Adhesion Molecules/*metabolism | 5 | 1.0 |
English Abstract | 4 | 0.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Antigens, CD/analysis | 3 | 0.0 |
Antigens, CD80/analysis | 2 | 4.0 |
Comparative Study | 11 | 0.0 |
Intercellular Adhesion Molecule-1/analysis | 2 | 1.0 |
Fluorescent Antibody Technique | 4 | 0.0 |
HLA-DR Antigens/analysis | 2 | 0.0 |
Prospective Studies | 3 | 0.0 |
Base Sequence | 6 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Risk Factors | 3 | 0.0 |
*Antigens, Differentiation | 3 | 3.0 |
Lymphocyte Function-Associated Antigen-1/metabolism | 2 | 4.0 |
Biological Markers/blood | 2 | 0.0 |
Intercellular Adhesion Molecule-1/blood | 2 | 2.0 |
Prognosis | 2 | 0.0 |
Cell Adhesion Molecules/*analysis | 4 | 3.0 |
Tumor Necrosis Factor-alpha/*analysis | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Signal Transduction | 2 | 0.0 |
Biopsy | 2 | 0.0 |
Follow-Up Studies | 3 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Lymphocyte Function-Associated Antigen-1/*immunology | 3 | 15.0 |
Antigens, CD4/immunology | 2 | 1.0 |
Mice, Nude | 2 | 0.0 |
Antibodies, Monoclonal/diagnostic use | 2 | 0.0 |
Phenotype | 2 | 0.0 |
*Cell Adhesion | 2 | 1.0 |
Immunity, Cellular | 2 | 0.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
Cell Adhesion Molecules/*genetics | 2 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 4 | 0.0 |
L-Selectin | 2 | 3.0 |
Antibody Specificity | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Intercellular Adhesion Molecule-1 | 4 | 1.0 |
Biological Markers | 3 | 0.0 |
Acute Disease | 3 | 0.0 |
Alkaline Phosphatase/analysis | 2 | 3.0 |
Antigens, CD/*analysis | 3 | 0.0 |
Bone Marrow/*pathology/physiology | 2 | 66.0 |
*Bone Marrow Cells | 2 | 0.0 |
Hematopoietic Stem Cells/*cytology/*pathology/physiology | 2 | 100.0 |
Leukemia, Myeloid/*pathology | 2 | 3.0 |
Macrophages/cytology/pathology | 2 | 66.0 |
Reference Values | 2 | 0.0 |
